195 related articles for article (PubMed ID: 37988169)
1. Galectin-3 aggravates microglial activation and tau transmission in tauopathy.
Siew JJ; Chen HM; Chiu FL; Lee CW; Chang YM; Chen HL; Nguyen TNA; Liao HT; Liu M; Hagar HT; Sun YC; Lai HL; Kuo MH; Blum D; Buée L; Jin LW; Chen SY; Ko TM; Huang JR; Kuo HC; Liu FT; Chern Y
J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 37988169
[TBL] [Abstract][Full Text] [Related]
2. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
4. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.
Vautheny A; Duwat C; Aurégan G; Joséphine C; Hérard AS; Jan C; Mitja J; Gipchtein P; Gaillard MC; Buée L; Blum D; Hantraye P; Bonvento G; Brouillet E; Cambon K; Bemelmans AP
Neurobiol Dis; 2021 Jul; 155():105398. PubMed ID: 34019997
[TBL] [Abstract][Full Text] [Related]
5. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Shi Y; Manis M; Long J; Wang K; Sullivan PM; Remolina Serrano J; Hoyle R; Holtzman DM
J Exp Med; 2019 Nov; 216(11):2546-2561. PubMed ID: 31601677
[TBL] [Abstract][Full Text] [Related]
6. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
7. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
[TBL] [Abstract][Full Text] [Related]
8. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
[TBL] [Abstract][Full Text] [Related]
9. Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22.
Kacířová M; Železná B; Blažková M; Holubová M; Popelová A; Kuneš J; Šedivá B; Maletínská L
J Neuroinflammation; 2021 Jun; 18(1):141. PubMed ID: 34158075
[TBL] [Abstract][Full Text] [Related]
10. P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy.
Carvalho K; Martin E; Ces A; Sarrazin N; Lagouge-Roussey P; Nous C; Boucherit L; Youssef I; Prigent A; Faivre E; Eddarkaoui S; Gauvrit T; Vieau D; Boluda S; Huin V; Fontaine B; Buée L; Delatour B; Dutar P; Sennlaub F; Guillonneau X; Blum D; Delarasse C;
Prog Neurobiol; 2021 Nov; 206():102139. PubMed ID: 34391810
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
12. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
15. Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer's disease.
Arroyo-García LE; Bachiller S; Ruiz R; Boza-Serrano A; Rodríguez-Moreno A; Deierborg T; Andrade-Talavera Y; Fisahn A
Transl Neurodegener; 2023 Feb; 12(1):6. PubMed ID: 36740709
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
Aulston B; Liu Q; Mante M; Florio J; Rissman RA; Yuan SH
J Alzheimers Dis; 2019; 72(2):575-585. PubMed ID: 31594233
[TBL] [Abstract][Full Text] [Related]
18. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology.
Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D
Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311
[TBL] [Abstract][Full Text] [Related]
19. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.
Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS
Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366
[TBL] [Abstract][Full Text] [Related]
20. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
Zhang L; Gai Y; Liu Y; Meng D; Zeng Y; Luo Y; Zhang H; Wang Z; Yang M; Li Y; Liu Y; Lai Y; Yang J; Wu G; Chen Y; Zhu J; Liu S; Yu T; Zeng J; Wang J; Zhu D; Wang X; Lan X; Liu R
Clin Transl Med; 2024 Mar; 14(3):e1623. PubMed ID: 38488468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
